We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRPT icon
4876
Freshpet
FRPT
$3.26B
$5K ﹤0.01%
76
-3,272
-98% -$214K
HPCO
4877
DELISTED
Hempacco Co., Inc. Common Stock
HPCO
$4.99K ﹤0.01%
1,278
-2
-0.2% -$11
VRP icon
4878
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$4.98K ﹤0.01%
224
-5
-2% -$110
ET icon
4879
Energy Transfer Partners
ET
$70.9B
$4.97K ﹤0.01%
391
-6,221
-94% -$78.8K
LUMO
4880
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4.96K ﹤0.01%
1,503
-1,708
-53% -$6.03K
FIEE
4881
FiEE Inc
FIEE
$31M
$4.96K ﹤0.01%
1,135
+355
+46% +$1.33K
ORKA
4882
Oruka Therapeutics
ORKA
$6.34B
$4.96K ﹤0.01%
204
-45
-18% -$1.11K
QVCGB
4883
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$4.96K ﹤0.01%
12
-46
-79% -$12.8K
VAXX
4884
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$4.94K ﹤0.01%
1,960
-13,002
-87% -$27.5K
BLPH
4885
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4.93K ﹤0.01%
7,150
+6,664
+1,371% +$42.9K
VOXX
4886
DELISTED
VOXX International Corporation Class A
VOXX
$4.9K ﹤0.01%
393
-752
-66% -$8.9K
CVLY
4887
DELISTED
Codorus Valley Bancorp Inc
CVLY
$4.9K ﹤0.01%
+250
New +$4.75K
BSQR
4888
DELISTED
BSQUARE Corporation
BSQR
$4.9K ﹤0.01%
3,766
-6,701
-64% -$7.87K
AMST icon
4889
Amesite
AMST
$6.55M
$4.89K ﹤0.01%
+1,356
New +$5.34K
MTRYU
4890
DELISTED
Monterey Innovation Acquisition Corp. Unit
MTRYU
$4.88K ﹤0.01%
445
FSI icon
4891
Flexible Solutions
FSI
$63.5M
$4.86K ﹤0.01%
1,819
-1,154
-39% -$3.38K
URTH icon
4892
iShares MSCI World ETF
URTH
$8.34B
$4.86K ﹤0.01%
+39
New +$4.68K
SNGX icon
4893
Soligenix
SNGX
$5.6M
$4.85K ﹤0.01%
431
-316
-42% -$5.49K
OKUR
4894
OnKure Therapeutics
OKUR
$164M
$4.85K ﹤0.01%
74
-174
-70% -$14K
BLNE
4895
Beeline Holdings
BLNE
$36.8M
$4.83K ﹤0.01%
150
+106
+241% +$4.11K
ENG
4896
DELISTED
ENGlobal Corp
ENG
$4.83K ﹤0.01%
1,603
-1,501
-48% -$4.91K
MTVA
4897
MetaVia Inc
MTVA
$7.39M
$4.83K ﹤0.01%
126
+65
+107% +$3.34K
ARMP icon
4898
Armata Pharmaceuticals
ARMP
$169M
$4.83K ﹤0.01%
4,234
+1,091
+35% +$1.59K
EXPR
4899
DELISTED
Express, Inc.
EXPR
$4.79K ﹤0.01%
404
-248
-38% -$3.6K
HOFV
4900
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$4.78K ﹤0.01%
457
+283
+163% +$2.29K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.